FDA pulls authorization for GSK-Vir’s COVID therapy amid rising BA.2 cases
The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology’s antibody therapy was no longer authorized to treat COVID-19 in the U.S. due to an increase in the proportion …
Read More